Medicine and Dentistry
Malignant Neoplasm
84%
Cohort Effect
59%
Observational Study
50%
Molecular Epidemiology
42%
Prevalence
32%
Biological Marker
31%
Cancer Risk
31%
Checklist
27%
Neurologic Disease
27%
Systematic Review
24%
Ganglioglioma
20%
Brain Tumor
18%
Cohort Analysis
18%
Breast Cancer
18%
Lung Cancer
18%
Cross Sectional Study
15%
Disease
15%
COVID-19
15%
Non-Hodgkin Lymphoma
14%
e-Health
13%
Amyotrophic Lateral Sclerosis
12%
Ecological Study
12%
Nervous System Physiology
12%
Diagnosis of Alzheimer's Disease
12%
Parkinson's Disease
12%
Meningioma
12%
Case-Control Study
11%
Childbirth
10%
Public Health
10%
Proportional Hazards Model
9%
B-Cell Chronic Lymphocytic Leukemia
8%
Diabetes
8%
Serositis
8%
Hormone Therapy
8%
Socioeconomic Status
8%
Epileptic Absence
7%
Carbon Metabolism
7%
Sex Ratio
7%
Body Mass Index
7%
Oncology
6%
Pyridoxine
6%
Somatomedin C
6%
Cardiovascular Disease
6%
Postmenopause
6%
Methionine
6%
Odds Ratio
6%
Child Growth
6%
Multiple Myeloma
6%
Endometrial Cancer
6%
Early Diagnosis
6%
Keyphrases
European Prospective Investigation Into Cancer
97%
STrengthening the Reporting of OBservational Studies in Epidemiology
42%
Epidemiology
36%
Molecular Epidemiology
36%
Confidence Interval
30%
Epidemiological Study
21%
Lung Cancer Risk
18%
Glioma
18%
Neuroepidemiology
18%
Educational Level
16%
Hazard Ratio
15%
Neurological Disorders
14%
Relative Index of Inequality
13%
Parkinson's Disease
13%
Alcohol Consumption
13%
Breast Cancer Risk
13%
Meningioma
13%
Prospective Cohort Study
13%
Pancreatic Cancer Risk
12%
Anthropometric Measurements
12%
Lymphoma
12%
Alzheimer's Disease Diagnosis
12%
Plasma 25-hydroxyvitamin D
12%
Neurological Function
12%
EHealth Tools
12%
Reporting Standards
12%
Incidence Studies
12%
Concussion
12%
Prevalence Study
12%
Body Mass Index
12%
Non-Hodgkin Lymphoma
11%
Coffee Consumption
10%
Risk Factors
10%
Cognitive Function
10%
European Countries
10%
Tea Consumption
9%
Pre-diagnostic
9%
Lung Cancer
9%
Odds Ratio
9%
Oncology
9%
Alzheimer's Disease
9%
Clinical Validity
9%
Coffee Intake
8%
Cigarette Smoking
8%
Low Risk
8%
Education Level
8%
Physical Activity
8%
Cotinine
8%
European Cohort
7%
Body Fat
7%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Amyotrophic Lateral Sclerosis
38%
Lung Cancer
37%
Biological Marker
29%
Cancer Incidence
24%
Disease
22%
Case-Control Study
19%
Parkinson's Disease
19%
Cotinine
19%
Prevalence
17%
Prospective Cohort Study
13%
Dystonia
12%
Breast Cancer
12%
Nonhodgkin Lymphoma
12%
Cross-Sectional Study
12%
Multiple Sclerosis
12%
Neurologic Disease
12%
Pancreas Cancer
12%
Neoplasm
10%
Cigarette Smoking
9%
Cohort Study
9%
Observational Study
8%
Prospective Study
8%
Epidemiology
7%
Pyridoxine
6%
Carcinogen
6%
Somatomedin C
6%
Abdominal Obesity
6%
Motor Neuron Disease
6%
Methionine
6%
Interferon
6%
Occupational Exposure
6%
Pyrethroid
6%
Leukemia
6%
Binding Protein
6%
Brain Tumor
6%
Alzheimer's Disease
6%
Alteplase
6%
Endometrium Cancer
6%
Cerebrovascular Disease
6%
Colorectal Cancer
6%
Head Injury
6%
Endocrine Therapy
6%
Intestine Flora
6%
Oral Contraceptive Agent
6%
Myeloid Leukemia
6%
Perfluorooctanoic Acid
6%
Perfluorooctanesulfonic Acid
6%
25 Hydroxyvitamin D
6%
Synapsin I
6%
